Skip to main content
Erschienen in: Pediatric Radiology 11/2023

Open Access 13.07.2023 | Original Article

Can we skip technetium-99 m sestamibi scintigraphy in pediatric primary hyperparathyroidism patients with positive neck ultrasound results?

verfasst von: Yudi He, Yanwen Luo, Siqi Jin, Ou Wang, Quan Liao, Qingli Zhu, He Liu

Erschienen in: Pediatric Radiology | Ausgabe 11/2023

Abstract

Background

Parathyroidectomy is the only curative treatment for primary hyperparathyroidism (PHPT). Ultrasound (US) and technetium-99 m sestamibi (99mTc-MIBI) scintigraphy are recommended as the first-line localization imaging modalities for PHPT in adults, but the value of preoperative imaging in pediatric patients has not been reported.

Objective

To evaluate the added value of 99mTc-MIBI scintigraphy in pediatric PHPT patients with positive ultrasound results.

Materials and methods

Pediatric patients (≤18 years old) who were diagnosed with PHPT and underwent surgical treatment in Peking Union Medical College Hospital between January 2003 and January 2021 were included in this study. Demographic and clinical characteristics, preoperative localization US, 99mTc-MIBI scintigraphy and pathology results were collected. Preoperative localization results were evaluated by comparison with surgical and pathological findings.

Results

There were 32 pediatric PHPT patients with median age of 14.7 ± 2.5 years who all proved to have single-gland disease without ectopic lesions. The median lesion size was 2.85 cm (range 1.0–5.8 cm). All patients underwent US and 99mTc-MIBI scintigraphy. Neck US demonstrated 100% sensitivity. Of 32 patients with a positive US, 99mTc-MIBI scintigraphy was concordant in 30 (93.8%). In 2 patients (6.3%), US reported suspected multigland disease, which was correctly diagnosed by 99mTc-MIBI scintigraphy as single lesions.

Conclusion

In pediatric PHPT patients, US achieved high sensitivity for preoperative localization. 99mTc-MIBI scintigraphy for pediatric patients with positive US results would not increase the sensitivity. Implementation of 99mTc-MIBI scintigraphy could increase the specificity in pediatric patients with multigland disease suspected by US.

Graphical abstract

Hinweise
Qingli Zhu and He Liu contributed equally to this work.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Primary hyperparathyroidism (PHPT) is characterized by abnormal elevation of serum calcium and parathyroid hormone (PTH) levels due to pathological parathyroid glands and involves multiple organ systems, including the skeletal, urinary and digestive systems [1]. Pediatric PHPT is less common compared to adult PHPT (incidences of 2–5/100000 and 1/1000, respectively). However, the percentage of symptomatic pediatric patients is significantly higher and treatment delays could cause a number of complications, such as nephrolithiasis, osteoporosis and bone fracture and may affect the growth and development of children [25].
Parathyroidectomy is the only curative treatment for PHPT [6]. The operative approach includes minimally invasive parathyroidectomy/unilateral neck exploration, which is generally applied to unilateral gland disease with relatively precise localization and bilateral neck exploration, which is usually conducted in patients with bilateral multiple gland disease, obscure localization of lesions or hereditary etiologies [7]. Therefore, preoperative localization of lesions is one of the crucial factors in planning the surgical approach to minimize trauma and achieve operative success.
Widely accepted first-line localization imaging examinations include neck ultrasound (US) and technetium-99 m sestamibi (99mTc-MIBI) scintigraphy [6, 810]. The American College of Radiology Appropriateness Criteria in 2021 and the American Association of Endocrine Surgeons guidelines in 2016 recommend that the choice of imaging examination should be based on expert advice and regional imaging capabilities [6, 11]. Koewar et al. proposed a stepwise manner of imaging studies in which US could be performed routinely while 99mTc-MIBI scintigraphy would be performed when negative US, failed operation or recurrence occurred [12]. Another study used a hypothetical model to build a localization modality in 513 PHPT patients (mean age 58.5 ± 14.1 years) and demonstrated that the value of 99mTc-MIBI scintigraphy after positive US was limited, since added 99mTc-MIBI scintigraphy could only change the operative plan made by referring to US positive results in 2.3% of patients [13]. Children and adolescents are a more sensitive population to radiation exposure, but data are near nonexistent regarding the value of 99mTc-MIBI scintigraphy in pediatric PHPT patients with positive US results.
This study aims to evaluate the added value of 99mTc-MIBI scintigraphy in pediatric PHPT patients who have positive US results.

Materials and methods

This retrospective study was approved by the Institutional Review Board of Peking Union Medical College Hospital. From January 2003 to January 2021, pediatric patients (≤18 years old) who were diagnosed with PHPT according to serum calcium and PTH levels and underwent surgical treatment were enrolled [14]. All patients underwent cervical US and 99mTc-MIBI scintigraphy for the purpose of localization before surgery. The exclusion criterion was patients with incomplete information on preoperative images. Demographics, clinical history and radiology reports were obtained from the electronic medical records. Data collected included age, sex, preoperative PTH, preoperative calcium, US and 99mTc-MIBI scintigraphy imaging findings, pathology results and clinical follow-up.
Preoperative US was performed by Y.J. and H.L., both radiologists with at least 5 years of experience in parathyroid ultrasonography using one of two US machines (IU22 or Epiq; Philips, Amsterdam, The Netherlands) and a broadband linear array probe (L12–5 MHz). For each suspicious lesion identified, longitudinal and transverse views using grayscale and Doppler modes were obtained. The position of the lesions, lesion size, echo pattern and blood flow were recorded. The sonographic appearance of the adjacent thyroid gland was evaluated to provide a differential diagnosis between parathyroid gland lesions and nodular goiters.
Patients received intravenous injection of 99mTc-MIBI (Atom Hitech Co., Ltd, Beijing, China) at a dose of 10~20 mCi according to routine clinical practice. Planar images of the neck and upper chest were obtained 20 min and 120 min after administration with a gamma camera and a pinhole collimator. Images of single photon emission computed tomography/CT (SPECT/CT) were acquired after 120 min on a 64-slice Philips Precedence device (Philips, Amsterdam, The Netherlands). SPECT was performed in a 128 × 128 matrix with a zoom factor of 1.0 and 32 projections over 360°. CT was performed with a current of 30 mAs, voltage of 120 kV and slice thickness of 3 mm. Each examination was independently reviewed by 2 experienced radiologists (Y.P. and Q.P.), subspecialists in endocrine imaging with more than 5 years of experience each.
The accuracy of preoperative localization was evaluated using operative and histological findings as the reference standards. The cervical region was divided into quadrants with a vertical line drawn along the midline of the neck and a horizontal line through the middle thyroid. The preoperative location was classified as left superior, left inferior, right superior, right inferior or ectopic and compared to actual location identifed at surgery.
Parathyroidectomy was conducted within 2 weeks of preoperative localization. Operation procedures were obtained from medical records focusing on operation approach (unilateral or bilateral) and intraoperative findings (size and position of lesions). Operative cure was defined as a postoperative calcium level that remained normal during a follow-up period of at least 6 months [6]. Histological findings (according to the World Health Organization [WHO] classification standard) provided etiological information [15].
Statistical analysis was conducted using SPSS 25.0 software (IBM Inc, Armonk, NY). Categorical variables were described as frequencies and percentages. Continuous variables were described as the mean ± standard deviation (SD) or median value and range. Sensitivity was calculated to reveal the effectiveness of multiple preoperative localization methods. A P-value of <0.05 was considered statistically significant.

Results

Demographic and clinical characteristics

Demographic and clinical characteristics are summarized in Table 1. A total of 32 PHPT patients who underwent surgical treatment with a median age of 14.7 ± 2.5 years old (range 9–18 years old) were included. Of 32 patients, 14 (43.8%) were female. Preoperative PTH and calcium levels were 926.60 ± 864.95 pg/ml and 3.03 ± 0.39 mmol/l, respectively. The median lesion size was 2.85 cm (range 1.00–5.80 cm). All 32 patients (100%) had single-gland disease. Of the 32 children in our series, 5 (15.6%) were also diagnosed with multiple endocrine neoplasia type 1 (MEN1). Most lesions (21/32, 65.6%) were parathyroid adenoma, followed by atypical adenoma (5/32, 15.6%) and hyperplasia (6/32, 18.8%). No ectopic lesions were reported. All patients achieved operative success and the curative rate was 100%. Of the five MEN1 patients, three had recurrent lesions during 1–7 years of follow-up after the initial parathyroidectomy.
Table 1
Demographic and clinical characteristics of pediatric primary hyperparathyroidism patients
 
Value (n=32)
Age, years (mean ± SD)
14.7 ± 2.5
Sex
 
Female
14 (43.8%)
Male
18 (56.2%)
Preoperative PTH, pg/ml (mean ± SD)
(12.0–68.0)
926.60 ± 864.95
Preoperative Ca, mmol/l (mean ± SD)
(2.13–2.70)
3.03 ± 0.39
Subtype
 
Sporadic
27 (84.4%)
MEN1
5 (15.6%)
Operative findings
 
Left sided, superior
8 (25.0%)
Left sided, inferior
10 (31.3%)
Right sided, superior
4 (12.5%)
Right sided, inferior
10 (31.3%)
Ectopic
0 (0%)
Lesion size, cm (median, range)
2.85 (1.00, 5.80)
 >2 cm
24 (75.0%)
Histological findings
 
Adenoma
21 (65.6%)
Atypical adenoma
5 (15.6%)
Hyperplasia
6 (18.8%)
Ca calcium, MEN1 multiple endocrine neoplasia type 1, PTH parathyroid hormone

Preoperative localization

A positive US was defined as patients with US findings suggestive of parathyroid lesions or indeterminate nodules. Of 32 patients who underwent US and 99mTc-MIBI scintigraphy, all had a positive US result, 30 patients (93.8%) had consistent findings on US and 99mTc-MIBI scintigraphy and 2 (6.3%) had discordant preoperative localization (Fig. 1).
In 30 patients with concordant imaging results, surgical findings confirmed a single-gland lesion. The most frequent histological type was adenoma, which occurred in 20 patients (66.7%), followed by hyperplasia in 6 (20%) and atypical adenoma in 4 (13.3%). Of the 2 patients with discordant localization results, case 1 was sporadic PHPT with a single left-sided adenoma. Neck US identified one left-sided nodule (maximum diameter 2.8 cm) and two right-sided nodules (maximum diameter 1.3 cm and 2.3 cm respectively). 99mTc-MIBI scintigraphy indicated a suspected gland on the left side. Bilateral neck exploration was conducted and proved that two right-sided nodules found by US were thyroid nodular goiter. Case 2 was diagnosed as multiple endocrine neoplasia (MEN)1 with an atypical left-sided adenoma. Neck US revealed one left-sided nodule (maximum diameter 2.9 cm) and one right-sided nodule (maximum diameter 2.1 cm). 99mTc-MIBI scintigraphy revealed one left-sided abnormal gland. The patient underwent bilateral neck exploration and single-gland resection on the left side. No other parathyroid gland lesions were found. In summary, the sensitivity of US localization was 100% and the accuracy was 93.8%.
Across the 32 patients, US reported 35 nodules. Among the true positive lesions, 32 (100%) were hypoechoic with oval shapes, circumscribed margins and internal blood flow on color Doppler mode. Cystic changes were found in 4 nodules (12.5%) and a hyperechoic focus was found in 1 nodule (3.1%). Neck US and 99mTc-MIBI scintigraphy images of a parathyroid gland adenoma with concordant localization are shown in Fig. 2. Another case with discordant localization results on US and 99mTc-MIBI scintigraphy is shown in Fig. 3.

Discussion

PHPT is less prevalent but more severe in pediatric patients than in adults and parathyroidectomy is the only curative therapy. Preoperative localization plays a crucial role in achieving operative success. First-line imaging localization modalities include US and 99mTc-MIBI scintigraphy which have a comparable diagnosed efficacy in adults [8]. A recent study revealed that adding 99mTc-MIBI scintigraphy after positive US results might have limited value since 99mTc-MIBI scintigraphy can only correct the operative plan in 2.3% of patients and the proportion is 0.35% when the lesion size is over 1.2 cm [13]. Ebner et al. revealed a similar operative success in three groups with only US, only 99mTc-MIBI scintigraphy, or US-99mTc-MIBI scintigraphy matched positive results, indicating that one type of imaging examination with positive results might be adequate for preoperative localization [16]. Children and adolescents are a special population and should be exposed to as little radiation exposure as possible. There are limited studies in PHPT imaging analysis focusing on the pediatric population, lacking the evidence to elaborate on the value of a second imaging examination after obtaining a positive US result for children and adolescents. Our study shows that preoperative US localization had a high sensitivity (100%) and accuracy (93.8%) in this pediatric cohort while 99mTc-MIBI scintigraphy only corrected localization in 6.3% patients after positive US results, which is similar to what is already known.
In our study, parathyroid lesions were solitary, large in size and had eutopic localization.
Lesion size can be a contributing factor to imaging localization efficacy. With increases in lesion size, the sensitivity of imaging examinations also increases [17]. Yalon et al. confirmed that the proportion of patients with positive US who received correction by 99mTc-MIBI scintigraphy decreased to 0.35% (1/287) when the lesion size was over 1.2 cm, compared to 2.3% (12/513) in the whole cohort [13]. For the pediatric population, lesion size or weight was quite different among multiple cohorts. The reported mean lesion weight varys from less than 0.4 g to more than 5 g [1820]. In our group, the median lesion maximum diameter of parathyroid gland lesions was 2.85 cm (range 1.0–5.8 cm) and 75% were over 2 cm. This could help explain the outstanding performance of US.
Multigland disease is one of the most difficult situations for preoperative localization imaging. It is widely accepted that there is an association between multigland disease and MEN1 in the pediatric population. MEN1 patients may have have a higher incidence of multigland disease [3, 21]. In our study, 5 (15.6%) patients were diagnosed with MEN1 and no multigland disease was found, nevertheless 3 in 5 MEN1 patients had recurrent lesions after a follow-up of 1–7 years. To our knowledge, sufficient evidence that the combination of US and 99mTc-MIBI scintigraphy could increase the sensitivity and specificity compared to single US in an underage population with multigland disease is lacking and further study might be needed.
Ectopic glands are another challenge for localization [10]. The proportion of ectopic adenomas in adult patients is 6–16% [22]. In two studies with 52 (<19 years old) and 86 (<22 years old) patients, ectopic lesions accounted for 9.6% and 25%, respectively [22, 23]. In our group, no ectopic location was reported according to surgical findings. Thus, a larger cohort might be needed for further study.
The above features of our cohort might explain the excellent performance of US. It would be interesting to include PHPT patients with negative US and further discuss the performance of 99mTc-MIBI scintigraphy in such patients in future studies.
There are several limitations of this study. First, the PHPT patients were enrolled from a national tertiary care referral center; thus, they represented more severe conditions which might lead to selection bias. Second, since this is a retrospective study, it was difficult for radiologists to be completely blinded to other imaging examinations before reaching a diagnosis. A future prospective study is warranted. Third, although our cohort is one of the largest pediatric PHPT cohorts focusing on imaging analysis, we only enrolled 32 patients. Sampling error might be the possible reason why this study has a higher percentage in which MIBI would dictate the surgical approach compared to an adult PHPT cohort [13].

Conclusion

In our cohort, parathyroid lesions of pediatric PHPT patients were solitary, large in size and had eutopic localization. Neck US has high sensitivity for identifying abnormal glands and is useful for preoperative localization, while adding 99mTc-MIBI scintigraphy for those with positive US results would not improve the sensitivity. Implementation of 99mTc-MIBI scintigraphy might increase the specificity in pediatric patients with suspected multigland disease as shown on US.

Acknowledgements

The authors thank the Department of Nuclear Medicine of Peking Union Medical College Hospital for their suggestions in interpretations of 99mTc-MIBI scintigraphy results and providing the 99mTc-MIBI scintigraphy figures.

Declarations

Written informed consent was signed by legally authorized representatives of the patients. The Institutional Review Board of Peking Union Medical College Hospital (PUMCH) has reviewed the protocol of this manuscript and has determined that this study is exempt from full IRB review since it is a retrospective study.

Conflicts of interest

None
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Pädiatrie

Kombi-Abonnement

Mit e.Med Pädiatrie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Pädiatrie, den Premium-Inhalten der pädiatrischen Fachzeitschriften, inklusive einer gedruckten Pädiatrie-Zeitschrift Ihrer Wahl.

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

Literatur
1.
2.
Zurück zum Zitat McKenna K, Dunbar NS, Parham K (2021) Why is primary hyperparathyroidism more severe in children? Med Hypotheses 147:110482 McKenna K, Dunbar NS, Parham K (2021) Why is primary hyperparathyroidism more severe in children? Med Hypotheses 147:110482
3.
Zurück zum Zitat Lo HB, Tebben PJ (2016) Primary hyperparathyroidism in children and adolescents. Hyperparathyroidism A Clin Caseb 75:117–128CrossRef Lo HB, Tebben PJ (2016) Primary hyperparathyroidism in children and adolescents. Hyperparathyroidism A Clin Caseb 75:117–128CrossRef
4.
Zurück zum Zitat Jovanovic M, Paunovic I, Zdravkovic V et al (2020) Case-control study of primary hyperparathyroidism in juvenile vs. adult patients. Int J Pediatr Otorhinolaryngol 131:109895 Jovanovic M, Paunovic I, Zdravkovic V et al (2020) Case-control study of primary hyperparathyroidism in juvenile vs. adult patients. Int J Pediatr Otorhinolaryngol 131:109895
5.
Zurück zum Zitat Zivaljevic V, Jovanovic M, Diklic A et al (2020) Differences in primary hyperparathyroidism characteristics between children and adolescents. J Pediatr Surg 55:1660–1662CrossRefPubMed Zivaljevic V, Jovanovic M, Diklic A et al (2020) Differences in primary hyperparathyroidism characteristics between children and adolescents. J Pediatr Surg 55:1660–1662CrossRefPubMed
6.
Zurück zum Zitat Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959–968CrossRefPubMed Wilhelm SM, Wang TS, Ruan DT et al (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959–968CrossRefPubMed
7.
Zurück zum Zitat Alagaratnam S, Brain C, Spoudeas H et al (2014) Surgical treatment of children with hyperparathyroidism: single centre experience. J Pediatr Surg 49:1539–1543CrossRefPubMed Alagaratnam S, Brain C, Spoudeas H et al (2014) Surgical treatment of children with hyperparathyroidism: single centre experience. J Pediatr Surg 49:1539–1543CrossRefPubMed
8.
Zurück zum Zitat Moghadam RN, Amlelshahbaz AP, Namiranian N et al (2017) Comparative diagnostic performance of ultrasonography and 99mTc-Sestamibi scintigraphy for parathyroid adenoma in primary hyperparathyroidism; systematic review and meta-analysis. Asian Pacific J Cancer Prev 18:3195–3200 Moghadam RN, Amlelshahbaz AP, Namiranian N et al (2017) Comparative diagnostic performance of ultrasonography and 99mTc-Sestamibi scintigraphy for parathyroid adenoma in primary hyperparathyroidism; systematic review and meta-analysis. Asian Pacific J Cancer Prev 18:3195–3200
9.
Zurück zum Zitat Khalatbari H, Cheeney SHE, Manning SC, Parisi MT (2021) Pediatric hyperparathyroidism: review and imaging update. Pediatr Radiol 51:1106–1120CrossRefPubMed Khalatbari H, Cheeney SHE, Manning SC, Parisi MT (2021) Pediatric hyperparathyroidism: review and imaging update. Pediatr Radiol 51:1106–1120CrossRefPubMed
10.
Zurück zum Zitat Kuzminski SJ, Sosa JA, Hoang JK (2018) Update in parathyroid imaging. Magn Reson Imaging Clin N Am 26:151–166CrossRefPubMed Kuzminski SJ, Sosa JA, Hoang JK (2018) Update in parathyroid imaging. Magn Reson Imaging Clin N Am 26:151–166CrossRefPubMed
11.
Zurück zum Zitat Zander D, Bunch PM, Policeni B et al (2021) ACR Appropriateness Criteria® parathyroid adenoma. J Am Coll Radiol 18:S406–S422CrossRefPubMed Zander D, Bunch PM, Policeni B et al (2021) ACR Appropriateness Criteria® parathyroid adenoma. J Am Coll Radiol 18:S406–S422CrossRefPubMed
12.
Zurück zum Zitat Korwar V, Yuen Chang F, Teasdale E et al (2020) Stepwise approach for parathyroid localisation in primary hyperparathyroidism. World J Surg 44:803–809CrossRefPubMed Korwar V, Yuen Chang F, Teasdale E et al (2020) Stepwise approach for parathyroid localisation in primary hyperparathyroidism. World J Surg 44:803–809CrossRefPubMed
13.
Zurück zum Zitat Yalon T, Neymark M, Rottenberg A et al (2021) The added value of technetium-99 m sestamibi scan in patients with primary hyperparathyroidism and positive ultrasound. World J Surg 45:2148CrossRefPubMed Yalon T, Neymark M, Rottenberg A et al (2021) The added value of technetium-99 m sestamibi scan in patients with primary hyperparathyroidism and positive ultrasound. World J Surg 45:2148CrossRefPubMed
14.
Zurück zum Zitat Bandeira F, Griz L, Chaves N et al (2013) Diagnosis and management of primary hyperparathyroidism: a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq Bras Endocrinol Metabol 57:406–424CrossRefPubMed Bandeira F, Griz L, Chaves N et al (2013) Diagnosis and management of primary hyperparathyroidism: a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq Bras Endocrinol Metabol 57:406–424CrossRefPubMed
15.
Zurück zum Zitat Lloyd RV, Osamura RY, Klöppel G et al (2017) WHO classification of tumours of endocrine organs 4th, edn. International Agency for Research of Cancer, Lyon Lloyd RV, Osamura RY, Klöppel G et al (2017) WHO classification of tumours of endocrine organs 4th, edn. International Agency for Research of Cancer, Lyon
16.
Zurück zum Zitat Ebner Y, Garti-Gross Y, Margulis A et al (2015) Parathyroid surgery: correlation between pre-operative localization studies and surgical outcomes. Clin Endocrinol (Oxf) 83:733–738CrossRefPubMed Ebner Y, Garti-Gross Y, Margulis A et al (2015) Parathyroid surgery: correlation between pre-operative localization studies and surgical outcomes. Clin Endocrinol (Oxf) 83:733–738CrossRefPubMed
17.
Zurück zum Zitat Abd Elhameed Elsayed W, Ali RA (2019) Efficacy of scintigraphy, ultrasound and both scintigraphy and ultrasonography in preoperative detection and localization of primary hyperparathyroidism. Cureus 11(6):e4960 Abd Elhameed Elsayed W, Ali RA (2019) Efficacy of scintigraphy, ultrasound and both scintigraphy and ultrasonography in preoperative detection and localization of primary hyperparathyroidism. Cureus 11(6):e4960
18.
Zurück zum Zitat Mancilla EE, Levine MA, Adzick NS (2017) Outcomes of minimally invasive parathyroidectomy in pediatric patients with primary hyperparathyroidism owing to parathyroid adenoma: a single institution experience. J Pediatr Surg 52:188–191CrossRefPubMed Mancilla EE, Levine MA, Adzick NS (2017) Outcomes of minimally invasive parathyroidectomy in pediatric patients with primary hyperparathyroidism owing to parathyroid adenoma: a single institution experience. J Pediatr Surg 52:188–191CrossRefPubMed
19.
Zurück zum Zitat Bhadada SK, Bhansali A, Dutta P et al (2008) Characteristics of primary hyperparathyroidism in adolescents. J Pediatr Endocrinol Metab 21:1147–1153CrossRefPubMed Bhadada SK, Bhansali A, Dutta P et al (2008) Characteristics of primary hyperparathyroidism in adolescents. J Pediatr Endocrinol Metab 21:1147–1153CrossRefPubMed
20.
Zurück zum Zitat Paunovic I, Zivaljevic V, Stojanic R et al (2013) Primary hyperparathyroidism in children and young adults:–a single institution experience. Acta Chir Belg 113:35–39CrossRefPubMed Paunovic I, Zivaljevic V, Stojanic R et al (2013) Primary hyperparathyroidism in children and young adults:–a single institution experience. Acta Chir Belg 113:35–39CrossRefPubMed
21.
Zurück zum Zitat Saponaro F, Marcocci C, Cacciatore F et al (2018) Clinical profile of juvenile primary hyperparathyroidism: a prospective study. Endocrine 59:344–352CrossRefPubMed Saponaro F, Marcocci C, Cacciatore F et al (2018) Clinical profile of juvenile primary hyperparathyroidism: a prospective study. Endocrine 59:344–352CrossRefPubMed
22.
Zurück zum Zitat Rampp RD, Mancilla EE, Adzick NS et al (2020) Single gland, ectopic location: adenomas are common causes of primary hyperparathyroidism in children and adolescents. World J Surg 44:1518–1525CrossRefPubMedPubMedCentral Rampp RD, Mancilla EE, Adzick NS et al (2020) Single gland, ectopic location: adenomas are common causes of primary hyperparathyroidism in children and adolescents. World J Surg 44:1518–1525CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kollars J, Zarroug AE, van Heerden J et al (2005) Primary hyperparathyroidism in pediatric patients. Pediatrics 115:974–980CrossRefPubMed Kollars J, Zarroug AE, van Heerden J et al (2005) Primary hyperparathyroidism in pediatric patients. Pediatrics 115:974–980CrossRefPubMed
Metadaten
Titel
Can we skip technetium-99 m sestamibi scintigraphy in pediatric primary hyperparathyroidism patients with positive neck ultrasound results?
verfasst von
Yudi He
Yanwen Luo
Siqi Jin
Ou Wang
Quan Liao
Qingli Zhu
He Liu
Publikationsdatum
13.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 11/2023
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-023-05702-w

Weitere Artikel der Ausgabe 11/2023

Pediatric Radiology 11/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.